Form 8-K - Current report:
SEC Accession No. 0000950170-25-054707
Filing Date
2025-04-16
Accepted
2025-04-16 16:05:09
Documents
11
Period of Report
2025-04-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K atha-20250415.htm   iXBRL 8-K 51560
  Complete submission text file 0000950170-25-054707.txt   171433

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atha-20250415.xsd EX-101.SCH 26991
13 EXTRACTED XBRL INSTANCE DOCUMENT atha-20250415_htm.xml XML 4888
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

EIN.: 453368487 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39503 | Film No.: 25842734
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)